Testing Spectrosense EVA System for Detection of Pancreatic Cancer by Analyzing Volatile Organic Compounds (VOCs) in Exhaled Air
- Conditions
- Pancreatic Cancer
- Registration Number
- NCT01994681
- Lead Sponsor
- Rauscher, Gregory E., M.D. PA
- Brief Summary
Volatile Organic Compounds (VOC) in human breath are captured and analyzed by the Spectrosense EVA system, which is combination of a gas chromatography (GC) and software algorithm. The objective is to obtain a set or sets of VOC bio-markers that will provide the best discrimination between Pancreatic Cancer sick population and healthy population. The gold standard for identifying sick/healthy population is biopsy proven Pancreatic cancer.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- Age from 18 years old
- Pancreatic cancer positive biopsy
- Before any treatment
- Signed Informed Patient Consent
Exclusion Criteria
- Age under 18 years old
- Neoadjovant treatment
- Post surgery for Pancreatic cancer
- A history of any other cancer type, except skin cancer that is not melanoma
Healthy Group
Inclusion Criteria:
- Healthy patients
- No history of Pancreatic cancer
- Signed Informed Patient Consent
Exclusion Criteria:
- History of Pancreatic cancer
- Pancreatic cancer background in the family
- A history of any other cancer type, except skin cancer that is not melanoma
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Obtaining a set or sets of VOC bio-markers that will provide the best discrimination between Pancreatic Cancer sick population and healthy population. Baseline An optimization algorithm will select VOCs that will provide maximal sensitivity and specificity.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hackensack University Medical Center
🇺🇸Hackensack, New Jersey, United States